Drug Type Small molecule drug |
Synonyms (-)-(2R)-3-(2-methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine, (-)-10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine, 2-Methoxytrimeprazine + [13] |
Target |
Mechanism adrenergic receptor antagonists(Adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date JP (27 May 1960), |
Regulation- |
Molecular FormulaC19H24N2OS |
InChIKeyVRQVVMDWGGWHTJ-CQSZACIVSA-N |
CAS Registry60-99-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Levomepromazine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bipolar Disorder | JP | 27 May 1960 | |
Depressive Disorder | JP | 27 May 1960 | |
Schizophrenia | JP | 27 May 1960 | |
Behavioural disorders | US | - |
Not Applicable | - | kpixqkxqhj(wcvjkfvova) = mzjbmagrmb unejqabsmq (nolmepvqbs ) View more | - | 12 Sep 2019 | |||
kpixqkxqhj(wcvjkfvova) = wayjlgcdih unejqabsmq (nolmepvqbs ) View more |